Abstract
Background: Altered expression of N-glycans such as polylactosamine is observed in colon cancer. AHL, a polylactosamine specific lectin from Adenia hondala from a medicinal plant from the Passifloraceae family has been reported earlier.
Objective: The aim of the present study is to study the interaction of AHL with human colon cancer epithelial HT-29 cells and colon cancer tissues.
Methods: Cell viability was determined by MTT [3-[4, 5- dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium bromide] assay, while cell surface binding, apoptosis by Annexin-V-PI assay and ROS production using DCFDA [2’,7’ - dichlorofluorescindiacetate] kit method were analysed by flowcytometry, immunohistochemistry was performed using biotinylated AHL, protein purification by affinity chromatography using asialofetuin-coupled Sepharose -4B column.
Results: AHL strongly binds to HT-29 cells with a Mean Fluorescence Intensity of 12.4, which could be blocked by competing glycoprotein asialofetuin. AHL inhibits HT-29 cell growth in a dose and time-dependent manner with IC50 of 2.5 μg/mL and differentially binds to human normal and cancerous tissues. AHL induces apoptosis and slight necrosis in HT-29 cells with an increase in the early apoptotic population of 25.1 and 36% for 24 h and 48 h respectively and necrotic population of 1.5 and 4.6% at 24 h and 48 h respectively as revealed by Annexin-V-PI assay. AHL induces the release of Reactive Oxygen Species in HT-29 cells in a dose-dependent manner.
Conclusion: To the best of knowledge, this is the first report on lectin from Adenia hondala which is not a RIP with apoptotic and necrotic effects. These findings support the promising potential of AHL in cancer research.
Keywords: AHL, apoptosis, necrosis, HT-29 cells, histochemistry, ROS.
Graphical Abstract
[http://dx.doi.org/10.1021/acsbiomaterials.7b00037] [PMID: 29805991]
[http://dx.doi.org/10.1146/annurev.iy.02.040184.000535] [PMID: 6085749]
[http://dx.doi.org/10.1038/314053a0] [PMID: 2579340]
[PMID: 10668205]
[http://dx.doi.org/10.1016/j.bbagen.2011.12.001]
[http://dx.doi.org/10.1016/1056-8719(94)00052-6] [PMID: 7727802]
[http://dx.doi.org/10.1007/s10719-018-9843-6] [PMID: 30306293]
[http://dx.doi.org/10.1016/S0021-9258(20)79875-3] [PMID: 4137945]
[http://dx.doi.org/10.1006/abio.1994.1410] [PMID: 7810865]
[PMID: 1985783]
[http://dx.doi.org/10.1007/s00204-012-0906-3] [PMID: 22811024]
[http://dx.doi.org/10.1016/j.abb.2008.12.003] [PMID: 19111670]
[http://dx.doi.org/10.3390/molecules20033791] [PMID: 25730388]
[http://dx.doi.org/10.1016/j.biopha.2017.06.081] [PMID: 28686979]
[http://dx.doi.org/10.1016/j.toxicon.2007.02.020] [PMID: 17434551]
[http://dx.doi.org/10.1186/1423-0127-16-10] [PMID: 19272170]
[PMID: 10226520]
[http://dx.doi.org/10.3390/molecules25112562] [PMID: 32486427]
[http://dx.doi.org/10.1016/S0955-0674(03)00002-4] [PMID: 12648682]
[http://dx.doi.org/10.2174/156720209789630375] [PMID: 19807658]
[http://dx.doi.org/10.1007/978-3-642-81681-9_1]